Cyclin D1 is frequently overexpressed in a large number of cancers, including colorectal, gastric cancer, nonsmall cell lung cancer, and glioma by diverse mechanisms such as genomic amplification, chromosomal translocations, disruption of normal intercellular trafficking, and proteolysis [22–25]. This evidence concerns the gene CCND1 and central nervous system cancer.